Leadless pacing in peri-procedural settings

Leadless pacemakers’ (LPs) main advantage over the traditional transvenous permanent pacemakers (TV-PPMs) is the absence of leads and subcutaneous pocket. These intracardiac pacemakers have been shown in observational studies to reduce long-term complications as compared with TV-PPM mainly by reducing the need for re-intervention. Two major advantages of this technology are the lower rate of infection (absence of pocket and lower rate of bacterial seeding) and lead-related complications (dislodgment). Hence, these advantages are more accentuated after transcutaneous valve replacement or valve surgery and clinical situations where it is important to reduce systemic infections and endocarditis. In this review, we highlight the role of LP in patients after transcutaneous and surgical valve replacements.